MX2007013230A - Uso de una formulacion en aerosol de clobetasol para tratar psoriasis. - Google Patents
Uso de una formulacion en aerosol de clobetasol para tratar psoriasis.Info
- Publication number
- MX2007013230A MX2007013230A MX2007013230A MX2007013230A MX2007013230A MX 2007013230 A MX2007013230 A MX 2007013230A MX 2007013230 A MX2007013230 A MX 2007013230A MX 2007013230 A MX2007013230 A MX 2007013230A MX 2007013230 A MX2007013230 A MX 2007013230A
- Authority
- MX
- Mexico
- Prior art keywords
- spray formulation
- treatment psoriasis
- psoriasis
- clobetasol
- pharmaceutical composition
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 3
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 title abstract 3
- 229960002842 clobetasol Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007921 spray Substances 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 229960004703 clobetasol propionate Drugs 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 abstract 1
- 239000003945 anionic surfactant Substances 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La actual invencion proporciona una composicion farmaceutica para tratar psoriasis, para ser rociada sobre la piel con psoriasis diariamente durante por lo menos 4 semanas, la composicion contiene una cantidad eficaz de propionato de clobetasol. La composicion farmaceutica preferida contiene propionato de clobetasol, alcohol etilico miristato de isopropilo y surfactante anionico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67494605P | 2005-04-25 | 2005-04-25 | |
| PCT/US2006/014903 WO2006115987A2 (en) | 2005-04-25 | 2006-04-20 | Use of a clobetasol spray formulation to treat psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007013230A true MX2007013230A (es) | 2008-04-17 |
Family
ID=37215257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007013230A MX2007013230A (es) | 2005-04-25 | 2006-04-20 | Uso de una formulacion en aerosol de clobetasol para tratar psoriasis. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20060239929A1 (es) |
| EP (1) | EP1885373B1 (es) |
| JP (1) | JP2008539236A (es) |
| KR (2) | KR20110108426A (es) |
| CN (1) | CN101208096A (es) |
| AU (1) | AU2006241285B2 (es) |
| BR (1) | BRPI0608334A2 (es) |
| CA (1) | CA2607434A1 (es) |
| DK (1) | DK1885373T3 (es) |
| ES (1) | ES2539634T3 (es) |
| HU (1) | HUE025462T2 (es) |
| MX (1) | MX2007013230A (es) |
| PL (1) | PL1885373T3 (es) |
| PT (1) | PT1885373E (es) |
| RU (1) | RU2397769C2 (es) |
| SI (1) | SI1885373T1 (es) |
| WO (1) | WO2006115987A2 (es) |
| ZA (1) | ZA200709327B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010129707A1 (en) * | 2009-05-05 | 2010-11-11 | Amgen Inc. | Etanercept in combination with glucocorticoids for use in treating psoriasis |
| WO2011026076A2 (en) | 2009-08-31 | 2011-03-03 | Dr. Reddy's Laboratories Ltd. | Topical formulations comprising a steroid |
| US10080760B2 (en) * | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
| WO2012053007A1 (en) | 2010-10-21 | 2012-04-26 | Cadila Healthcare Limited | Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis |
| US9789123B2 (en) | 2010-10-21 | 2017-10-17 | Cadila Healthcare Limited | Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis |
| US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
| EA201691808A8 (ru) | 2014-03-11 | 2017-04-28 | Промиус Фарма, Ллк | Кортикостероидные композиции для местного применения |
| US20160184431A1 (en) * | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
| US20180235882A1 (en) | 2015-09-02 | 2018-08-23 | Cadila Healthcare Limited | Topical compositions comprising corticosteroids |
| KR102399484B1 (ko) | 2015-09-15 | 2022-05-17 | 주식회사 엘지생활건강 | 건선 치료제 전달을 위한 용해성 미세바늘 패치 |
| KR102631435B1 (ko) | 2016-06-10 | 2024-01-29 | 주식회사 엘지생활건강 | 타박상 치료제 전달을 위한 용해성 미세바늘 패치 |
| US20210069214A1 (en) * | 2019-09-06 | 2021-03-11 | Encore Dermatology, Inc. | Topical compositions comprising a corticosteroid for the treatment of psoriasis in pediatric patients |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972920A (en) * | 1998-02-12 | 1999-10-26 | Dermalogix Partners, Inc. | Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
| US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| US5886038A (en) * | 1998-03-24 | 1999-03-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| FR2761600B1 (fr) * | 1998-06-19 | 2000-03-31 | Oreal | Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant |
| US6579512B2 (en) * | 2001-06-15 | 2003-06-17 | Crutchfield, Iii Charles E. | Topical steroid spray |
-
2006
- 2006-04-20 ES ES06750845.7T patent/ES2539634T3/es active Active
- 2006-04-20 CN CNA2006800229419A patent/CN101208096A/zh active Pending
- 2006-04-20 HU HUE06750845A patent/HUE025462T2/en unknown
- 2006-04-20 MX MX2007013230A patent/MX2007013230A/es unknown
- 2006-04-20 JP JP2008508939A patent/JP2008539236A/ja active Pending
- 2006-04-20 KR KR1020117022050A patent/KR20110108426A/ko not_active Ceased
- 2006-04-20 PT PT67508457T patent/PT1885373E/pt unknown
- 2006-04-20 RU RU2007143420/14A patent/RU2397769C2/ru active
- 2006-04-20 US US11/408,105 patent/US20060239929A1/en not_active Abandoned
- 2006-04-20 WO PCT/US2006/014903 patent/WO2006115987A2/en not_active Ceased
- 2006-04-20 BR BRPI0608334-0A patent/BRPI0608334A2/pt not_active Application Discontinuation
- 2006-04-20 CA CA002607434A patent/CA2607434A1/en not_active Abandoned
- 2006-04-20 KR KR1020077026561A patent/KR20080047312A/ko not_active Ceased
- 2006-04-20 AU AU2006241285A patent/AU2006241285B2/en active Active
- 2006-04-20 PL PL06750845T patent/PL1885373T3/pl unknown
- 2006-04-20 SI SI200631954T patent/SI1885373T1/sl unknown
- 2006-04-20 DK DK06750845.7T patent/DK1885373T3/en active
- 2006-04-20 EP EP20060750845 patent/EP1885373B1/en active Active
-
2007
- 2007-10-30 ZA ZA200709327A patent/ZA200709327B/xx unknown
-
2014
- 2014-01-17 US US14/157,579 patent/US20140148426A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2607434A1 (en) | 2006-11-02 |
| RU2397769C2 (ru) | 2010-08-27 |
| US20060239929A1 (en) | 2006-10-26 |
| DK1885373T3 (en) | 2015-08-10 |
| BRPI0608334A2 (pt) | 2009-12-01 |
| WO2006115987A3 (en) | 2006-12-14 |
| PT1885373E (pt) | 2015-09-10 |
| PL1885373T3 (pl) | 2015-12-31 |
| AU2006241285A1 (en) | 2006-11-02 |
| ES2539634T3 (es) | 2015-07-02 |
| WO2006115987A8 (en) | 2008-10-16 |
| ZA200709327B (en) | 2009-01-28 |
| JP2008539236A (ja) | 2008-11-13 |
| SI1885373T1 (sl) | 2016-03-31 |
| EP1885373B1 (en) | 2015-05-20 |
| EP1885373A4 (en) | 2010-08-18 |
| KR20080047312A (ko) | 2008-05-28 |
| RU2007143420A (ru) | 2009-06-10 |
| WO2006115987A2 (en) | 2006-11-02 |
| HUE025462T2 (en) | 2016-02-29 |
| KR20110108426A (ko) | 2011-10-05 |
| EP1885373A2 (en) | 2008-02-13 |
| CN101208096A (zh) | 2008-06-25 |
| US20140148426A1 (en) | 2014-05-29 |
| AU2006241285B2 (en) | 2011-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010001293A3 (en) | Sprayable skin protectant formulation and method of use | |
| MX2007013230A (es) | Uso de una formulacion en aerosol de clobetasol para tratar psoriasis. | |
| WO2008010167A3 (en) | Treatment articles capable of delivering intensive care and overall treatment simultaneously | |
| NZ539841A (en) | Hydroxyethylamine derivatives for the treatment of alzheimer's disease | |
| BRPI0113670B8 (pt) | composição farmacêutica e método para tratar hipogonadismo | |
| WO2007113851A3 (en) | Novel compositions for hair disorders and process of preparation thereof | |
| PL370795A1 (en) | Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne | |
| WO2005032471A3 (en) | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | |
| ATE366760T1 (de) | Folienzusammensetzung zur lokalen anwendung und verwendung zur freisetzung von aktivstoffen | |
| MX2009010675A (es) | Formulaciones farmaceuticas de moleculas de la hormona liberadora de la hormona delcrecimiento humana. | |
| WO2007130113A3 (en) | Parathyroid hormone analogues and methods of use | |
| WO2005051914A8 (en) | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | |
| WO2007098591A3 (en) | Topical nail formulation | |
| WO2011059324A3 (en) | Composition for topical application, uses thereof, applicator device and kit of parts | |
| TWI256292B (en) | Reduction inhibitory agent for active oxygen eliminating activity | |
| EP2494965A3 (en) | Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy | |
| WO2010018385A3 (en) | Chemical composition for skin care formulations | |
| TW200637542A (en) | Lipase inhibitor, preventing and treating agent of skin disease | |
| SI1771180T2 (sl) | Zmes v obliki pršila, ki vsebuje kombinacijo klobetazol propionata in kalcitrola, alkoholna faza in oljna faza | |
| AU2003229269A1 (en) | Deposition method for endoprostheses provided for constantly administering medicaments | |
| ID27755A (id) | Komposisi parfum | |
| MY139169A (en) | Methods of spray-coating deodorant, antibacterial and antifungal agent and deodorized and antibacterially and antifungally treated articles | |
| CY1116851T1 (el) | Χρηση συνθεσης ψεκασματος κλομπεταζολης για την θεραπευτικη αγωγη της ψωριασης | |
| DE602006005637D1 (de) | Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst | |
| BR0315845A (pt) | Compostos de pirazina como moduladores de crf |